Home › NDC Lookup › Ingredients › Bacitracin Zinc Neomycin Sulfate Polymyx... › 70082-0017-01
Dealmed Triple Antibiotic BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g Ointment, 144 packets — NDC 70082-0017-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Dealmed Triple Antibiotic BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g Ointment, 144 packets — NDC 70082-017-01 (Billing 70082-0017-01) · Product 70082-017

by Dealmed Medical Supplies, LLC. · 144 PACKET in 1 BOX (70082-017-01) / .5 g in 1 PACKET

NDC 70082-017-01 (billing 70082-0017-01) is a package of 144 packets of Dealmed Triple Antibiotic BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g Ointment from Dealmed Medical Supplies, LLC., marketed since Nov 2025 and currently FDA-listed. It is the main listing for product NDC 70082-017, its only package size.

NDC 70082-0017-01
🏷️ FDA NDC (as labeled) 70082-017-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Sep 3, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70082-017-01
Product NDC 70082-017
11-digit billing NDC 70082001701
RxCUI 204602
UNII 89Y4M234ES, 057Y626693, 19371312D4
Application # M004
SPL Set ID b3f1e834-4e8f-49f6-af0d-38097ae4f928
Established class (EPC) Aminoglycoside Antibacterial; Polymyxin-class Antibacterial
Physiologic effect Decreased Cell Wall Synthesis & Repair
Chemical class Aminoglycosides; Polymyxins
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-11-05
Route TOPICAL
Dosage form OINTMENT
Substance BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Quick answers for NDC 70082-017-01
  • RxCUI (RxNorm): 204602
  • 11-digit billing NDC: 70082001701
Why two NDCs? The FDA registers this code as 70082-017-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 70082-0017-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antibiotics for topical use class.

Drug family (ATC) Other antibiotics for topical use, Other antibacterials, Antibiotics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 About the active ingredient MedlinePlus · NLM
General information about the ingredient itself — the description of this specific product follows below.

Neomycin, polymyxin, and bacitracin combination is used to prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria.

Read the full MedlinePlus article ↗
🧪 What is this product?

Dealmed Triple Antibiotic is a topical ointment available over the counter that contains three antibiotic ingredients: bacitracin zinc, neomycin sulfate, and polymyxin B sulfate. These antibiotics are typically used together to help prevent bacterial infection in minor cuts, scrapes, and wounds. This product is marketed as an OTC monograph drug, meaning it follows FDA's established category rules for topical antibiotic products.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70082-0017-01 70082-017-01 You're viewing this Main listing 144 PACKET in 1 BOX (70082-017-01) / .5 g in 1 PACKET 2025-11-05 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Triple Antibiotic 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g 47682-0934-73 Unifirst 25 packets — — FDA listed —
Premier Value Triple Antibiotic 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g 68016-0320-05 Premier 1 tube — — FDA listed —
triple antibiotic 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g 00363-1332-01 Walgreens 1 tube — — FDA listed —
Triple Antibiotic 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g 47682-0392-35 Unifirst 144 packets — — FDA listed —
Triple Antibiotic 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g 61010-5600-01 Safetec 9 g — — FDA listed —
Triple Antibiotic 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g 53329-0087-01 Medline 1 tube — — FDA listed —
Triple Antibiotic 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g 68016-0319-01 Premier 1 tube — — FDA listed —
MyMedic Triple Antibiotic 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g 43473-0310-01 Nantong 9 g — — FDA listed —
Travel Savvy First Aid Triple Antibiotic 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g 59961-0143-45 Bellegrove 450 packets — — FDA listed —
careone triple antibiotic 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g 41520-0067-28 American 1 tube — — FDA listed —
Meret Triple Antibiotic 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/g 43473-0312-01 Nantong 9 g — — FDA listed —
Dealmed Triple Antibiotic 400 [USP'U]/g; 3.5 mg/g; 5000 [USP'U]/gthis 70082-0017-01 Dealmed 144 packets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Nov 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 4T6H12BN9U
    Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also statesPetrollatum.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerDealmed Medical Supplies, LLC.
FDA applicationM004 (OTC MONOGRAPH DRUG)
Labeler code70082
First marketedNov 2025
Product typeHuman Otc Drug
Portfolio8 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 13 words ▾

Uses: First aid to help prevent infection in minor cuts, scrapes, and burns.

⏱️ Dosage and Administration 34 words ▾

Directions: Clean affected area • Apply a small amount of this product (equal to the surface area of the tip of finger) 1 to 3 times daily • May cover with a sterile bandage.

⚠️ Warnings 82 words ▾

Warnings: For external use only. Keep out of reach of children. If ingested, get medical help or contact a Poison Control Center directly. Do not use: Internally •In the eyes or over large areas of the body, or on puncture wounds, animal bites or serious burns •For more than 1 week unless directed by a doctor • If allergic to any of the ingredients. Stop use, ask a doctor if: Condition persists or gets worse • A rash or allergic reaction developes.

🧪 Active Ingredient 26 words ▾

Active Ingredients (in each gram) Bacitracin zinc (400 units bacitracin) Neomycin sulfate (3.5 mg Neomycin) Polymyxin B sulfate (Polymycin B 5000 units) Purpose First Aid Antibiotic

🧪 Inactive Ingredients 3 words ▾

Inactive Ingredients: Petrollatum.

🎯 Purpose 4 words ▾

Purpose First Aid Antibiotic

📄 Do Not Use 41 words ▾

Do not use: Internally •In the eyes or over large areas of the body, or on puncture wounds, animal bites or serious burns •For more than 1 week unless directed by a doctor • If allergic to any of the ingredients.

📄 Stop Use and Ask a Doctor If 18 words ▾

Stop use, ask a doctor if: Condition persists or gets worse • A rash or allergic reaction developes.

📄 Keep Out of Reach of Children 18 words ▾

Keep out of reach of children. If ingested, get medical help or contact a Poison Control Center directly.

📄 Questions or Comments 4 words ▾

Questions or Comments: 1-800-456-7077

📄 Package Label / Principal Display Panel 6 words ▾

Package Labeling: Outer Package2 Inner Package2

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE — the ingredient across all brands.

Top reported reactions

Dyspnoea89
Diarrhoea86
Nausea75
Dizziness73
Rash69
Pneumonia68
Malaise66

Age at onset

Neonate1
Infant4
Child1
Adolescent2
Adult29
Elderly16

Reporter sex

1,649 reports
Male · 35%
Female · 64%
Unknown · 1%

Serious outcomes

Disabling35
Reports over time (by year) — tap or hover for the count & year
2022 2023 2024 2026 11 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 70082-017-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 70082-0017-01, written without dashes as 70082001701. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 70082-0017-01, the first segment (70082) is the labeler code FDA assigned to Dealmed Medical Supplies, LLC.; the middle segment (0017) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Dealmed Medical Supplies, LLC.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Dealmed Medical Supplies, LLC. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 70082-0016-01 · Dealmed 70082-0111-16 · DealMed →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.